Wednesday, November 30, 2011

Affymetrix to buy eBioscience for $330M

Affymetrix Inc. said Wednesday it signed an agreement to acquire eBioscience Inc.
Santa Clara-based Affymetrix (NASDAQ:AFFX) said the purchase price is $330 million in cash, subject to certain customary adjustments. Affymetrix makes products and services related to genetic analysis for the life science research and clinical health care markets.
San Diego-based eBioscience is a private company specializing in flow cytometry and immunoassay reagents for immunology and oncology research and diagnostics. EBioscience is expected to have 2011 sales of more than $70 million.

No comments:

Post a Comment